New small proteins designed to stop bacterial infections
Researchers designed miniprotein inhibitors to neutralize bacterial adhesins and prevent infections.
Scientists designed new miniprotein inhibitors to neutralize bacterial adhesins. These proteins target FimH and Abp chaperone usher pili adhesins.
The design process was de novo. This means the proteins were created from scratch. These proteins target adhesins, which are virulence factors critical in host-pathogen interactions.
The designed antagonists have high specificity and stability. They disrupt bacterial recognition of host receptors and block biofilm formation.
The inhibitors were designed for uropathogenic Escherichia coli and Acinetobacter baumannii. These bacteria are implicated in uncomplicated and catheter-associated urinary tract infections (UTI).
The proteins were effective in treating and preventing murine models of uncomplicated and catheter-associated UTIs in vivo. This matters because multidrug-resistant bacterial infections necessitate new antimicrobial strategies.
Key facts
- Miniproteins were de novo designed to bind to FimH and Abp chaperone usher pili adhesins.
- The inhibitors block biofilm formation and disrupt bacterial recognition of host receptors.
- The design was effective in murine models of uncomplicated and catheter-associated urinary tract infections (UTI).